BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:http://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250624
DTEND;VALUE=DATE:20250627
DTSTAMP:20260515T093947
CREATED:20250225T182337Z
LAST-MODIFIED:20250228T133908Z
UID:40588-1750723200-1750982399@www.pharmajournalist.com
SUMMARY:CPHI & PMEC China 2025
DESCRIPTION:CPHI & PMEC China is Asia’s premier pharmaceutical event for sourcing\, networking\, learning and innovation with over 20 years’ experience of bringing together Chinese and global pharma professionals. \n \nCPHI & PMEC China 2025 will cover more than 230\,000 square meters of exhibition area\, attract over 90\,000 global attendees and 3\,500 exhibitors\, and hold more than 100 conferences during the exhibition. \nCPHI & PMEC China 2025 showcases a wide range of pharmaceutical products and services\, including: active pharmaceutical ingredients\, Intermediates & fine chemicals\, excipients\, finished dosage formulation\, biopharmaceuticals\, natural extracts\, CMO & CRO\, machinery & equipment\, packaging & drug delivery\, laboratory equipment\, cleanroom & pollution control etc. \nClick here to register now.
URL:http://www.pharmajournalist.com/event/cphi-pmec-china-2025/
LOCATION:Shanghai New International Expo Centre\, Shanghai\, China
ORGANIZER;CN="Shanghai Sinoexpo Informa Markets International Exhibition Co.%2C Ltd.":MAILTO:CPHImarketing@imsinioexpo.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250624
DTEND;VALUE=DATE:20250627
DTSTAMP:20260515T093947
CREATED:20250304T114230Z
LAST-MODIFIED:20250304T114358Z
UID:40629-1750723200-1750982399@www.pharmajournalist.com
SUMMARY:5th Medical Device Software Development Summit
DESCRIPTION:The 5th Medical Device Software Development Summit is your must-attend opportunity to gain actionable strategies\, real-world case studies\, and expert insights to confidently develop\, secure\, and regulate cutting-edge medical device software – without compromise. \nDedicated to navigating the complexities of US and global regulations\, addressing cybersecurity vulnerabilities\, and managing legacy device updates\, this summit unites 120+ industry leaders – from medical device giants to innovative start-ups – to explore actionable strategies\, share best practices\, and collaborate on solutions for ensuring the continuous compliance and security of cutting-edge software in a rapidly evolving market. \nWhat Will you Gain: \n\nStay Ahead of Regulatory Changes: Gain insights from Biogen\, Werfen\, and Olympus on the latest FDA\, EU MDR\, and global compliance updates\, ensuring your products meet evolving standards.\nSecure & Accelerate Your Software: Learn how Medtronic\, RETINA-AI\, and Abbott are addressing cybersecurity risks\, enhancing software validation\, and leveraging AI-powered innovation to streamline development processes.\nUnlock AI for Safer\, Faster Development: Discover how HeartSciences\, Kheiron\, and Globe Biomedical are utilizing AI to expedite software testing\, improve validation\, and bolster cybersecurity\, leading to safer and more efficient medical device development.\n\n\nDon’t miss this summit – join us in Boston this June to stay ahead\, gain crucial insights\, benchmark and fuse knowledge from software\, QA\, RA and product teams to align innovation in software with evolving processes\, cybersecurity\, and global regulatory frameworks in new and legacy devices. \nView the full Event Guide here: https://ter.li/cziksw
URL:http://www.pharmajournalist.com/event/5th-medical-device-software-development-summit/
LOCATION:The Royal Sonesta Boston\, 40 Edwin H Land Blvd\, Cambridge\, MA\, 02142\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250624
DTEND;VALUE=DATE:20250627
DTSTAMP:20260515T093947
CREATED:20250409T112357Z
LAST-MODIFIED:20250409T112504Z
UID:40904-1750723200-1750982399@www.pharmajournalist.com
SUMMARY:8th International Neoantigen Summit
DESCRIPTION:2024 saw a wealth of clinical progression with Nouscom\, CureVac\, Transgene and other pioneering companies paving the way for neoantigen based vaccines and therapies to become tolerable\, durable medicines to effectively treat cancer.\nReady to unite the global neoantigen community\, the 8th International Neoantigen Summit 2025 returns to address key challenges in the discovery\, translation and clinical development of safe and cost-effective neoantigen therapies and vaccines to attract investors and ultimately improve the health of patients. \nJoin neoantigen leaders from the likes of AstraZeneca\, Geneos Therapeutics\, Evaxion Biotech and many more at this end-to-end meeting\, focusing on the development of durable\, neoantigen cancer vaccines and cell therapies. With the potential to deliver safe\, efficacious personalized or off-the-shelf therapeutic options to patients\, this is your chance to collaborate and accelerate the translation of neoantigen-based therapies from discovery to clinical success. \nTo know more visit: https://ter.li/zdfjes
URL:http://www.pharmajournalist.com/event/8th-international-neoantigen-summit/
LOCATION:Steigenberger Airport Hotel Amsterdam\, Stationsplein Zuid-West 951\, 1117 CE Schiphol\, Netherlands\, 1117 CE\, Netherlands
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250625
DTEND;VALUE=DATE:20250627
DTSTAMP:20260515T093947
CREATED:20250401T093821Z
LAST-MODIFIED:20250401T093821Z
UID:40798-1750809600-1750982399@www.pharmajournalist.com
SUMMARY:5th Annual Induced Proximity-Based Drug Discovery Summit
DESCRIPTION:Coming to San Diego\, CA for the first time\, the 5th Induced Proximity-Based Drug Discovery Summit returns as your intimate learning and networking setting to cover the depth and breadth of proximity-based drugs from stabilization\, phosphorylation and methylation to novel lysosome-based degradation to finally drug the undruggable. \nEnabling leaders in biopharma and academia to identify novel MoAs\, leverage advanced technologies to find targets more efficiently\, and optimize chemical structures for more effective therapeutic agents for a wide range of disease areas. Alongside key strategic updates on DUBTACs\, RIPTACs\, tPRIMEs\, RiboTACs and more\, it provides granular technical and scientific insights to overcome challenges in accessing diverse chemical matter and designing selective\, potent small molecules of tomorrow. \nJoin 70+ experts in drug discovery\, medicinal chemistry\, chemical biology and structural biology from leading companies such as Genentech\, Halda Therapeutics and Stablix and gain access to genuinely innovative research from breakthrough companies and academic labs pioneering the next generation of induced proximity-based drugs beyond the ubiquitin proteasome system \nDownload the event guide for full details: https://ter.li/blor1c
URL:http://www.pharmajournalist.com/event/5th-annual-induced-proximity-based-drug-discovery-summit/
LOCATION:The Westin San Diego Bayview\, 400 W Broadway\, San Diego\, CA\, 92101\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250626
DTEND;VALUE=DATE:20250628
DTSTAMP:20260515T093947
CREATED:20250404T112624Z
LAST-MODIFIED:20250404T112624Z
UID:40863-1750896000-1751068799@www.pharmajournalist.com
SUMMARY:4th Liquid Biopsy for Precision Oncology East Coast
DESCRIPTION:The 4th Liquid Biopsy for Precision Oncology East Coast Summit returns to Boston with a refreshed agenda\, sharpened focus\, and a renewed mission: to accelerate access to more sensitive\, less invasive testing by addressing the most pressing challenges across the entire patient care continuum. \nThis year\, we’ve updated the Summit’s name and expanded its scope. What began with a focus on early detection and recurrence monitoring has grown to reflect the full breadth of innovation across the liquid biopsy space – from MRD and treatment response to emerging applications in rare diseases\, novel analytes\, and beyond. \nBringing together leaders in Biomarker Development\, Translational Research\, Diagnostics\, Clinical Development\, Pathology\, and beyond\, this is the go-to East Coast forum for diving deep into the barriers slowing the adoption of liquid biopsy technologies. \nTake home actionable insights to ensure you’re maximizing the value of liquid biopsies in your therapeutic development strategies. Shape the future of precision oncology and be part of the conversations that will drive meaningful change for patients worldwide. \nWhat’s more\, this event is completely *FREE for drug developers and researchers for the entire 2 day conference\, so claim your pass here (it only takes 2 minutes): https://ter.li/mr0yvh \nIf you need to explore the full event guide in more detail\, feel free to download the brochure here: https://ter.li/mxugsc \nT&Cs are available on the website.
URL:http://www.pharmajournalist.com/event/4th-liquid-biopsy-for-precision-oncology-east-coast/
LOCATION:The Colonnade Hotel\, 120 Huntington Ave\, Boston\, MA\, 02116\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR